Medicine Classification




5 SEPTEMBER NEW ZEALAND GAZETTE 2745

Sevoflurane
Simvastatin
Sodium ditiocarb
Sodium ipodate
Solanaceous alkaloids; and their salts; in medicines containing more than 0.15% of solanaceous alkaloids calculated as hyoscyamine
Somatropin
Sparfloxacin
Spirapril
Steroid hormones; either natural or synthetic, which exhibit anabolic activity
Stramonium; alkaloids of; and their salts; in medicines containing 0.15% or more of alkaloids calculated as hyoscyamine
Sultamicillin; and its salts
Sumatriptan; and its salts
Tamsulosin hydrochloride
Tazobactam
T cell receptor antibody
Teicoplanin
Terazosin; and its salts
Thymoxamine;
Tibolone
Ticlopidine; and its salts
Tinzaparin
Tirilazad mesylate
Tolrestat
Trandolapril
Trazodone
Tretinoin
Triptorelin
Tropisetron
Ursodeoxycholic acid
Valaciclovir
Venlafaxine
Vigabatrin
Xamoterol
Zalcitabine
Zinc; and its salts; in medicines for internal use containing more than 25 mg of elemental zinc per recommended daily dose
Zuclopenthixol; and its salts and esters

Schedule 2

Restricted Medicines

Alcohol, absolute; in medicines for internal and external use, except when compounded in a medicine
Aminacrine; and its salts; in medicines for external use
Amphotericin; for buccal use
Aspirin; in slow-release forms; in enteric-coated forms containing more than 300 mg per dose form
Astemizole
Beclomethasone dipropionate; in aqueous nasal sprays delivering 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms
Budesonide; in aqueous nasal sprays delivering 50 micrograms per actuation when the maximum recommended daily dose is no greater than 400 micrograms
Bismuth; and its salts; in medicines for internal use
Beta 2-adrenoceptor agonists; except in medicines for inhalation or for parenteral use
Carbuterol; and its salts; except when contained in medicines for inhalation or for parenteral use
Ciclopirox; for dermatological use in medicines containing more than 1% of ciclopirox
Cimetidine; in medicines which are sold in the manufacturer’s original pack containing not more than 14 days’ supply
Clindamycin; and its salts; in medicines for dermatological use
Clotrimazole; in medicines for vaginal use when in pack sizes equivalent to one course of treatment
Cholestyramine resin
Diclofenac; and its salts; in tablets or capsules containing 25 mg or less and in pack sizes of not more than 30 tablets or capsules
Dithranol; and its esters
Econazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment
Ether; except when used as a vehicle for a topical dose form
Ethyl chloride
Famotidine; in medicines which are sold in the manufacturer’s original pack containing not more than 14 days’ supply
Fenoterol; and its salts; except in medicines for inhalation or for parenteral use
Flunisolide; in aqueous nasal sprays delivering 50 micrograms per actuation when the maximum recommended daily dose is no greater than 200 micrograms
Glycopyrronium; and its salts; except in medicines for parenteral use
Hexoprenaline; and its salts; except in medicines for inhalation or for parenteral use
Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 1% or less and more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container
Hydrocortisone; and hydrocortisone acetate; in rectal medicines in cream or ointment form containing 1% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of not more than 35 grams per container
Hyoscine; and its salts; in medicines for transdermal use and oral use
Hyoscine-N butyl bromide; in medicines for oral use
Hyoscyamine; and its salts; in medicines containing 0.15% and less of hyoscyamine; except in forms for parenteral use
Ibuprofen; in liquid form for oral use in medicines which are sold in the manufacturer’s original pack containing 200 millilitres or less in volume and in strengths of 100 milligrams or less per 5 millilitres
Insulins
Itraconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 106


NZLII PDF NZ Gazette 1996, No 106





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Classification, Medicines, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines